论文部分内容阅读
目的 探讨颅内静脉系统血栓形成早期诊断方法及观察纤溶抗凝治疗疗效。方法 详细分析 30例颅内静脉系统血栓患者的临床表现及影像学特征 ,并将应用纤溶抗凝治疗的 16例患者作为观察组 ,回顾性调查 14例未用纤溶抗凝治疗的患者作为对照组进行疗效对比观察分析。结果 核磁共振 (MRI)和磁共振血管成像(MRA)能直接显示脑静脉窦闭塞及其血栓栓子 ;早期纤溶抗凝治疗观察组与对照组比较从症状缓解、体征恢复、痊愈率及死亡率方面均有显著差异。结论 MRI和 MRA对颅内静脉系统血栓早期诊断具有重要意义 ,早期纤溶抗凝治疗可以改善颅内静脉系统血栓患者预后 ,具有较高的临床应用价值。
Objective To investigate the early diagnosis of intracranial venous thrombosis and observe the therapeutic effect of fibrinolytic anticoagulation. Methods The clinical manifestations and imaging features of thrombosis in 30 patients with intracranial venous thrombosis were analyzed in detail. Twenty-six patients treated with fibrinolytic anticoagulation as the observation group were retrospectively investigated in 14 patients without fibrinolysis and anticoagulation The control group compared the efficacy of observation and analysis. Results Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) could directly show cerebral venous sinus occlusion and thromboembolism. Early fibrinolytic anticoagulation treatment group compared with the control group, relieved symptoms, recovery, recovery rate and death There are significant differences in rates. Conclusion MRI and MRA are of great significance for the early diagnosis of thrombus in the intracranial venous system. Early fibrinolysis anticoagulation therapy can improve the prognosis of patients with intracranial venous thrombosis and has high clinical value.